drugset / Trial / NCT03726242

Peripheral Nociceptive Effects of Levcromakalim

NCT03726242

Completed 20 enrolled Danish Headache Center
RandomizedCrossoverQuadruple-blindOther

Summary

Intradermal and intramuscular injection of levcromacalim and placebo (sterile saline) on the forehead and forearm of healthy subjects and the following will be investigated: 1. Prevalence and intensity of pain 2. Prevalence and intensity of itching 3. Occurrence and intensity of local redness and swelling 4. Occurrence and intensity of local changes in skin temperature and blood flow

Timeline

Start
2018-11-01
Primary completion
2019-01-20
Completion
2019-01-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Levcromakalim Small molecule 0.05 ml Intrathecal
Comparator Levcromakalim Small molecule 150 ug/ml Intrathecal
Comparator Levcromakalim Small molecule 0.2 ml Intrathecal

Indications

No indication recorded.